首页 / 资料库 / 文献详情

Cobalamin Deficient Thrombotic Microangiopathy: a case of TTP or Pseudo-TTP

MD Adam FranksAnne JarrellAdrienne MaysTammy Bannister

2018West Virginia Medical JournalImmunology and Microbiology被引 2开放获取

出版方页面 →

摘要

A thrombotic microangiopathy (TMA) occurs when a patient presents with microangiopathic hemolytic anemia, thrombocytopenia and organ damage. There are many causes of TMAs, but thrombotic thrombocytopenic purpura (TTP) must always be considered because of its high mortality rate. Treatment with therapeutic plasma exchange and transfusions can reduce the mortality rate but those treatments carry their own morbidity. Severe cobalamin deficiency can cause a clinical picture similar to TTP. Understanding the pathologic changes of this pseudo-TTP can allow physicians to suspect this difference early in the clinical course. In the following case, elevations in homocysteine and methylmalonic acid, as well as changes in the CBC, allowed this distinction to be identified early, minimizing potentially dangerous treatments.

引用本文(GB/T 7714)

MD Adam Franks, Anne Jarrell, Adrienne Mays, 等. Cobalamin Deficient Thrombotic Microangiopathy: a case of TTP or Pseudo-TTP[J]. West Virginia Medical Journal, 2018.

引文网络

参考文献与被引分析加载中…

DOI:https://doi.org/10.21885/wvmj.2018.5

本站仅收录题录与摘要供学习参考,全文版权归属出版方;如有侵权请联系我们删除。